Safety and Efficacy of Bexagliflozin Compared to Placebo as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
Status:
Completed
Trial end date:
2019-01-23
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the effect of bexagliflozin compared to placebo
as an add-on therapy to metformin in lowering hemoglobin A1c (HbA1c) levels in subjects with
type 2 diabetes mellitus (T2DM).